| mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
| mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0004 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.19 |
0.0004 |
| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.0005 |
| mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |